Evaluation of Mobile Education Program in Patients With Atrial Fibrillation. (NCT07030335) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of Mobile Education Program in Patients With Atrial Fibrillation.
Turkey (Türkiye)70 participantsStarted 2025-06
Plain-language summary
This study was conducted to determine the effect of a mobile education program and telephone follow-up on the knowledge level, symptom management and quality of life of patients with atrial fibrillation.
The study aims to answer the following questions.
1. Does the mobile education program and telephone follow-up have an effect on increasing the level of knowledge in patients with AF in the intervention group compared to the control group?
2. Does the mobile education program and telephone follow-up have an effect on reducing symptom severity in patients with AF in the intervention group compared to the control group?
3. Does the mobile education program and telephone follow-up have an effect on improving the quality of life in patients with AF in the intervention group compared to the control group?
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years of age or older.
* Being literate.
* Atrial Fibrillation diagnosis.
* No cognitive and communication disabilities.
* Not having a diagnosed psychiatric illness.
* Ability to use technological devices.
* Having and using a smart phone with Android operating system and internet access.
* Acceptance to participate in the study.
Exclusion Criteria:
* Diagnosis of rheumatic valve disease, moderate/severe mitral stenosis and previous valve surgery.
* Functional class III or IV according to the New York Heart Association (NYHA) classification.
* Patients with existing or planned pacemaker, ICD (Implantable Cardioverter Defibrillator) and patients with existing or planned Radiofrequency Ablation treatment will not be included in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The Jessa Atrial Fibrillation Knowledge Questionnaire
Timeframe: The measurement will be done at the beginning of the study (day 0) and at the end of the 12th week.
2
The University of Toronto Atrial Fibrillation Severity Scale
Timeframe: The measurement will be done at the beginning of the study (day 0) and at the end of the 12th week.
3
Effect of Atrial Fibrillation on Quality of Life Scale
Timeframe: The measurement will be done at the beginning of the study (day 0) and at the end of the 12th week.